AVR 4.03% $15.02 anteris technologies ltd

catalysts

  1. 920 Posts.
    I've posted something similar a few months back but we have yet to get the announcements we were waiting for.

    1. HSV Phase I (tick)
    2. CE Mark approval for Cardiocel
    3. HPV Phase I
    4. Update on adult trials with Cardiocel
    5. Update on pelvic floor and hernia repairs with Gynecel
    6. Update on stem cell reserach with CSIRO
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.